China to Build Africa’s First Insulin Plant in Nigeria

Nigeria is set to host Africa’s first local insulin manufacturing facility following a landmark agreement between the National Biotechnology Research and Development Agency (NBRDA) and Shanghai Haiqi Industrial Company Ltd of China.

The deal, signed in Abuja and witnessed by Nigeria’s Minister of Innovation, Science and Technology, Chief Uche Nnaji, marks a major step toward ending the country’s reliance on imported insulin. It also positions Nigeria as a continental hub for medical biotechnology, with the plant expected to serve the wider African market.

Chinese Ambassador to Nigeria, Yu Dunhai, who announced the initiative at a reception marking the 76th anniversary of the founding of the People’s Republic of China, said the project would transform diabetes management across Africa.

“This partnership is designed to make insulin more accessible, prevent diabetes-related complications, and promote Africa’s self-reliance in biotechnology,” Yu said.

NBRDA Director-General, Prof. Abdullahi Mustapha, signed the agreement on behalf of Nigeria, stressing that the facility would significantly reduce costs and improve treatment access for millions of people living with diabetes. Estimates suggest that the country could save up to $1 billion annually by producing insulin locally.

Deputy Senate President Barau Jibrin, represented by Senator Babangida Hussaini, conveyed President Bola Tinubu’s goodwill to China and reaffirmed Nigeria’s commitment to transparent and sustainable cooperation in critical sectors.

While the project is still at the agreement stage, experts describe it as a groundbreaking step that will not only strengthen Nigeria’s health system but also establish Africa’s first dedicated insulin plant, addressing a growing regional health challenge.